FierceBiotech6h
BMS' CAR-T cracks down on lupus, achieving sustained responses in phase 1
Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic ...
Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...
Yahoo Finance23h
Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
November 13, 2024--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to ...